Effect of Xuesaitong Soft Capsules on Major Risk Factors in Patients With Coronary Heart Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This trials aims to assess, in 240 eligible patients with coronary heart disease, the effects on level of high-sensitivity C-reactive protein (hsCRP) changes from baseline to 12 weeks of Xuesaitong Soft Capsules.
Epistemonikos ID: 14bc64bba05919da2fae5b65595ef1c01d44e722
First added on: May 22, 2024